Product overview
[Placeholder]
Composition
[Placeholder]
Results & data
[Placeholder — reported outcomes and statistics]

$999.00
5 mg · 1 lyophilized powder vial + 1 Bac. water vial (2 ml)
A triple agonist of the GIP, GLP-1 and glucagon receptors, designed to reduce appetite, increase satiety and regulate blood glucose.
[Placeholder]
[Placeholder]
[Placeholder — reported outcomes and statistics]
| Compound | TATRU |
|---|---|
| Strength | 5 mg |
Reviews
There are no reviews yet.